Author: Lynne Taylor

QALY denying access to cancer drugs: study

Patients in countries whose healthcare systems’ reimbursement decisions consider how much a cancer treatment costs per quality-adjusted life year achieved (CPQ) have less access to new cancer drugs than those in countries which do not use CPQ, according to a new study.

Read More